| Literature DB >> 35457173 |
Ilzira A Minigalieva1, Vladimir G Panov1,2, Vladimir B Gurvich1, Larisa I Privalova1, Svetlana V Klinova1, Boris A Katsnelson1.
Abstract
Our studies of exposure to binary mixtures of nanoparticles (TiO2 + SiO2; TiO2 + Al2O3 and SiO2 + Al2O3) based on mathematical modelling show that their combined subchronic toxicity can either be of an additive type or deviate from it depending on the outcome, dose ratio, and levels of effect. To characterize the type of toxicity of ternary mixtures of nanoparticles, we successfully tested a previously developed approach for assessing the combined toxicity of metal ions. In this approach, the effects are classified by a null, positive, or negative change in the toxicity of binary nanoparticle mixtures when modeled against the toxicity of the third agent added.Entities:
Keywords: combined toxicity; mathematical modelling; ternary nanoparticle mixtures
Mesh:
Substances:
Year: 2022 PMID: 35457173 PMCID: PMC9032812 DOI: 10.3390/ijms23084356
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Some functional indices of the rat organism following 18 intraperitoneal injections of MeO NPs in binary and ternary combinations administered during six weeks ( ± Sx).
| Indices | Control | Al2O3 + | Al2O3 + | TiO2 + | Al2O3 + |
|---|---|---|---|---|---|
| Group 1 | Group 2 | Group 3 | Group 4 | ||
| Initial body weight, g | 292.27 ± 5.020 | 287.08 ± 7.20 | 290.83 ± 7.50 | 291.67 ± 7.40 | 290.00 ± 5.50 |
| Final body weight, g | 332.27 ± 7.90 | 320.00 ± 3.50 | 322.50 ± 5.20 | 324.17 ± 7.70 | 334.55 ± 8.10 |
| Weight gain, % | 15.13 ± 1.80 | 13.41 ± 2.00 | 14.70 ± 1.80 | 12.58 ± 2.00 | 15.40 ± 2.00 |
| Number of head dips into holes in 3 min | 4.73 ± 0.94 | 5.08 ± 1.02 | 3.00 ± 0.59 | 4.42 ± 0.67 | 3.27 ± 0.78 |
| Number of squares crossed in 3 min | 8.18 ± 1.25 | 7.58 ± 1.17 | 5.00 ± 0.55 * | 7.58 ± 1.19 | 6.50 ± 1.09 |
| Summation threshold index, s | 14.27 ± 1.29 | 15.35 ± 0.85 | 14.88 ± 1.08 | 13.39 ± 0.86 | 14.41 ± 0.97 |
| Left kidney weight, g/100 g body weight | 0.30 ± 0.01 | 0.30 ± 0.01 | 0.29 ± 0.01 | 0.30 ± 0.01 | 0.28 ± 0.01 |
| Right kidney weight, g/100 g body weight | 0.31 ± 0.01 | 0.30 ± 0.01 | 0.30 ± 0.01 | 0.30 ± 0.01 | 0.29 ± 0.01 |
| Liver weight, g/100 g body weight | 3.08 ± 0.13 | 3.22 ± 0.18 | 3.22 ± 0.16 | 3.19 ± 0.13 | 3.09 ± 0.16 |
| Spleen weight, g/100 g body weight | 0.17 ± 0.01 | 0.18 ± 0.01 | 0.17 ± 0.01 | 0.18 ± 0.01 | 0.18 ± 0.01 |
| Left testis weight, g/100 g body weight | 0.55 ± 0.02 | 0.55 ± 0.01 | 0.55 ± 0.01 | 0.53 ± 0.01 | 0.53 ± 0.02 |
| Right testis weight, g/100 g body weight | 0.55 ± 0.02 | 0.54 ± 0.01 | 0.55 ± 0.01 | 0.53 ± 0.01 | 0.53 ± 0.02 |
| Brain weight, g/100 g body weight | 0.62 ± 0.01 | 0.61 ± 0.01 | 0.61 ± 0.01 | 0.61 ± 0.01 | 0.59 ± 0.01 * |
| Hemoglobin, g/L | 158.89 ± 1.16 | 147.33 ± 2.8 * | 146.00 ± 1.5 1 * | 151.25 ± 2.45 * | 147.75 ± 2.28 * |
| Erythrocytes, 1012/L | 7.93 ± 0.16 | 7.61 ± 0.24 | 7.48 ± 0.11 * | 7.52 ± 0.10 * | 7.83 ± 0.17 |
| Mean corpuscular volume, μm3 | 54.69 ± 0.86 | 52.17 ± 0.67 * | 52.36 ± 0.57 * | 54.94 ± 0.344 | 51.73 ± 0.93 * |
| Reticulocytes, ‰ | 13.63 ± 1.65 | 29.90 ± 1.28 * | 25.86 ± 1.61 * | 31.67 ± 2.73 * | 15.50 ± 1.41 1,2,3 |
| Hematocrit, % | 21.54 ± 0.21 | 20.03 ± 0.69 * | 19.59 ± 0.26 * | 20.65 ± 0.28 * | 20.20 ± 0.30 * |
| Thrombocytes, 103/μL | 847.25 ± 25.41 | 831.75 ± 54.09 | 926.57 ± 7.89 | 880.50 ± 34.53 | 882.25 ± 36.87 |
| Thrombocrit, % | 0.23 ± 0.02 | 0.24 ± 0.02 | 0.27 ± 0.01 | 0.25 ± 0.01 | 0.26 ± 0.01 |
| Leucocytes, 103/μL | 7.20 ± 0.37 | 9.10 ± 1.03 | 9.40 ± 0.83 * | 7.85 ± 0.67 | 7.78 ± 0.66 |
| Eosinophils, % | 2.20 ± 0.29 | 3.13 ± 0.484 | 3.57 ± 0.87 | 2.13 ± 0.40 | 3.00 ± 0.42 |
| Segmented neutrophils, % | 19.50 ± 0.64 | 20.000.82 | 20.43 ± 1.91 | 20.50 ± 0.98 | 20.75 ± 1.05 |
| Band neutrophils, % | 1.50 ± 0.17 | 1.00 ± 0.00 * | 2.29 ± 0.29 *,1 | 1.38 ± 0.18 2 | 1.63 ± 0.26 |
| Monocytes, % | 6.20 ± 0.39 | 6.75 ± 0.49 | 6.86 ± 0.34 | 6.38 ± 0.42 | 6.25 ± 0.45 |
| Lymphocytes, % | 70.60 ± 0.95 | 69.13 ± 0.91 | 66.71 ± 2.60 | 69.63 ± 1.13 | 68.50 ± 1.24 |
| Succinate dehydrogenase (SDH) in blood lymphocytes, number of formazan granules | 589.45 ± 16.55 | 562.67 ± 15.74 | 551.55 ± 20.54 | 530.42 ± 16.03 * | 561.64 ± 15.99 |
| Gamma-glutamyltransferase (GGT), IU/L | 2.26 ± 0.69 | 2.48 ± 0.45 | 3.98 ± 0.99 | 0.74 ± 0.30 2 | 1.10 ± 0.66 2 |
| Glucose, mol/L | 7.09 ± 0.26 | 6.10 ± 0.30 * | 6.64 ± 0.18 | 7.04 ± 0.29 | 7.08 ± 0.18 1 |
| Serum ceruloplasmin, mg/% | 33.14 ± 0.13 | 44.06 ± 1.53 * | 46.22 ± 2.35 * | 42.88 ± 1.44 * | 42.61 ± 1.88 * |
| Serum malondialdehyde (MDA), μmol/L | 3.51 ± 0.49 | 3.56 ± 0.48 | 5.10 ± 0.37 * | 4.57 ± 0.19 * | 4.28 ± 0.29 |
| Serum catalase, μmol/L | 1.34 ± 0.25 | 1.31 ± 0.22 | 1.18 ± 0.24 | 0.65 ± 0.12 * | 1.10 ± 0.21 |
| Reduced glutathione in whole blood, μmol/L | 26.82 ± 1.19 | 26.20 ± 0.87 | 28.44 ± 1.47 | 26.00 ± 1.39 2 | 22.55 ± 1.41 *,1,2 |
| Plasma sulfhydryl groups, mmol/L | 37.33 ± 7.38 | 36.93 ± 6.04 | 43.21 ± 6.99 | 42.72 ± 6.90 | 40.20 ± 6.66 |
| Serum total protein, g/L | 80.47 ± 1.42 | 80.49 ± 2.01 | 78.20 ± 1.33 | 78.93 ± 2.15 | 79.91 ± 1.82 |
| Serum albumin, g/L | 44.34 ± 0.61 | 41.31 ± 1.05 * | 39.58 ± 0.67 * | 40.18 ± 1.24 * | 41.91 ± 0.88 * |
| Serum globulin, g/L | 36.13 ± 1.22 | 39.18 ± 1.54 | 38.63 ± 1.06 | 38.75 ± 1.53 | 38.00 ± 1.40 |
| Atherogenic index of plasma | 1.24 ± 0.04 | 1.06 ± 0.05 * | 1.03 ± 0.03 * | 1.05 ± 0.05 * | 1.11 ± 0.04 * |
| Serum AST level, U/L | 218.44 ± 17.65 | 264.61 ± 25.72 | 236.81 ± 17.78 | 187.39 ± 5.07 2 | 213.91 ± 17.83 |
| Serum ALT level, U/L | 70.82 ± 3.24 | 66.46 ± 4.41 | 66.50 ± 1.66 | 63.94 ± 3.32 | 66.75 ± 3.55 |
| AST/ALT ratio | 3.12 ± 0.24 | 3.76 ± 0.39 | 3.55 ± 0.23 | 3.01 ± 0.23 | 3.22 ± 0.25 |
| Alkaline phosphatase, U/L | 193.64 ± 13.08 | 222.55 ± 13.71 | 240.48 ± 21.89 * | 236.53 ± 10.62 * | 200.30 ± 12.154 |
| Serum creatinine, μmol/L | 36.33 ± 1.46 | 34.46 ± 1.71 | 34.50 ± 1.49 | 33.89 ± 1.352 | 35.39 ± 1.03 |
| Serum bilirubin, μmol/L | 1.14 ± 0.13 | 1.31 ± 0.13 | 1.09 ± 0.14 | 0.98 ± 0.14 | 1.10 ± 0.16 |
| Serum Ca2+ concentration, mol/L | 2.61 ± 0.03 | 2.56 ± 0.04 | 2.57 ± 0.03 | 2.52 ± 0.05 | 2.58 ± 0.02 |
| Serum follicle-stimulating hormone, U/L | 0.14 ± 0.02 | 0.13 ± 0.01 | 0.11 ± 0.01 | 0.11 ± 0.01 | 0.14 ± 0.01 |
| Serum luteinizing hormone, U/L | 0.13 ± 0.02 | 0.94 ± 0.58 | 0.35 ± 0.21 | 0.77 ± 0.63 | 0.12 ± 0.01 |
| Serum prolactin, U/L | 7.85 ± 0.62 | 15.71 ± 4.51 | 8.22 ± 0.82 | 14.73 ± 5.25 | 6.84 ± 0.35 |
| Serum testosterone, nmol/L | 8.20 ± 3.40 | 9.77 ± 2.10 | 8.45 ± 4.01 | 16.28 ± 4.27 | 13.34 ± 8.17 |
| Serum lactate dehydrogenase, U/L | 1904.10 ± 296.03 | 2208.25 ± 290.47 | 2119.50 ± 305.84 | 1628.50 ± 149.27 | 1709.88 ± 246.58 |
| Serum uric acid, μmol/L | 120.50 ± 10.86 | 121.00 ± 11.99 | 122.00 ± 9.19 | 115.75 ± 8.69 | 123.63 ± 9.61 |
| Serum urea, mmol/L | 4.44 ± 0.34 | 3.59 ± 0.36 | 3.71 ± 0.27 | 3.73 ± 0.37 | 3.35 ± 0.42 |
| 24-h urine volume, mL | 29.67 ± 4.36 | 33.00 ± 2.50 | 24.86 ± 2.20 | 31.71 ± 5.64 | 26.86 ± 4.14 |
| Urinary coproporphyrin, nmol/L | 162.42 ± 31.78 | 135.37 ± 62.57 | 111.83 ± 39.84 | 155.14 ± 31.38 | 76.11 ± 24.08 |
| Daily coproporphyrin, μmol | 8.14 ± 3.60 | 4.63 ± 2.23 | 5.42 ± 2.46 | 5.91 ± 2.02 | 4.34 ± 2.23 |
| Delta-ALA in urine, μg/mL | 14.11 ± 3.52 | 13.87 ± 4.37 | 9.90 ± 3.98 | 12.61 ± 2.99 | 13.48 ± 5.22 |
| Urinary creatinine, mmol/L | 1.57 ± 0.11 | 1.54 ± 0.14 | 1.92 ± 0.13 | 1.85 ± 0.17 | 2.03 ± 0.19 1 |
| Creatinine clearance | 1.40 ± 0.15 | 1.50 ± 0.23 | 1.38 ± 0.08 | 1.60 ± 0.19 | 1.49 ± 0.19 |
| Urinary total protein, g/L | 190.43 ± 9.63 | 196.13 ± 20.43 | 193.36 ± 20.67 | 211.45 ± 37.18 | 233.13 ± 30.83 |
| Urine pH | 7.17 ± 0.17 | 6.79 ± 0.15 | 7.00 ± 0.29 | 6.93 ± 0.17 | 6.93 ± 0.37 |
| Urea in urine, mmol/L | 229.30 ± 16.00 | 211.22 ± 17.474 | 262.08 ± 19.23 | 238.15 ± 24.71 | 289.74 ± 28.72 |
| Uric acid in urine, μmol/L | 234.00 ± 38.97 | 204.29 ± 78.30 | 201.86 ± 64.52 | 213.00 ± 51.37 | 216.00 ± 52.97 |
Notes: * p < 0.05 compared to the control index; superscripted numbers are values that are statistically different from the indices in the groups designated by a corresponding number (based on the Student’s t-test).
Figure 1Examples of Class A three-factor toxicity: (a) antagonism or contradirectional effect of the Al2O3 + TiO2 combination (for different levels of effect and doses) on serum creatinine in the absence of a third agent changes (for all ratios of effects and doses) into (b) additivity in the presence of SiO2 NPs. MeO NP doses on the axes are plotted in mg per rat. Numbers on the isoboles show effect values (μmol/L).
Figure 2Examples of Class B three-factor toxicity: (a) unidirectional antagonism in the effect of SiO2 + Al2O3 nanoparticles on serum albumin changes in the absence of a third agent into (b) a single-factor effect of Al2O3 alone in the presence of TiO2 nanoparticles acting simultaneously in the background. MeO NP doses on the axes are plotted in mg per rat. Numbers on the isoboles show effect values (μmol/L).
Figure 3Examples of Class C three-factor toxicity: almost complete coincidence between the isobolograms for the combined effect of SiO2 + TiO2 nanoparticles on blood serum glucose (a) in the absence of and (b) in the presence of Al2O3 NPs. MeO NP doses on the axes are plotted in mg per rat. Numbers on the isoboles show effect values (μmol/L).
Figure 4An example of three-factor toxicity of undefined class: the combined effect of Al2O3 + TiO2 nanoparticles on alkaline phosphatase activity in blood serum (a) in the absence of a third factor, and (b) in the presence of SiO2 (see the text for interpretation). MeO NP doses on the axes are plotted in mg per rat. Numbers on the isoboles show effect values (U/L).
Morphometric indices of damage to the epithelium of proximal convoluted tubules in rat kidneys following subchronic exposure to binary and ternary mixtures of Al2O3, TiO2, and SiO2 nanoparticles ( ± Sx).
| Indices | Control | Al2O3 + TiO2 | Al2O3 + SiO2 | TiO2 + SiO2 | Al2O3 + SiO2+ TiO2 (Half Dose) | Al2O3 + SiO2+ TiO2 (Full Dose) |
|---|---|---|---|---|---|---|
| Brush border loss, % | 1.49 ± 0.56 | 6.45 ± 1.07 * | 4.23 ± 0.80 * | 3.64 ± 0.70 *# | 3.06 ± 0.84 # | 7.19 ± 1.47 * |
| Epithelial desquamation, % | 0.00 ± 0.00 | 0.97 ± 0.48 * | 0.29 ± 0.17 | 0.14 ± 0.14 | 0.66 ± 0.47 | 1.04 ± 0.39 * |
Notes: * statistically significant difference from the control value; # from the value of the group exposed to a full-dose ternary mixture (p < 0.05 by the Student’s t-test).
Figure 5An example of Class A three-factor toxicity. The isobolograms of Al2O3 + TiO2 combined subchronic nephrotoxicity as assessed by desquamation of renal tubular epithelial cells as follows: (a) additivity of the unidirectional actions in the absence of a third agent; (b) synergism in the presence of SiO2 NPs. MeO NP doses on the axes are plotted in mg per rat. Numbers on the isoboles show effect values (in %).
Morphometric indices of rat liver and spleen following subchronic exposure to binary and ternary mixtures of Al2O3, TiO2 and SiO2 ( ± Sx).
| Indices | Control | Al2O3 + | Al2O3 + | TiO2 + | Al2O3 + | Al2O3 + |
|---|---|---|---|---|---|---|
|
| ||||||
| Prokaryotic hepatocytes per 100 liver cells | 10.30 ± 1.09 | 29.45 ±1.47 * | 41.88 ± 1.72 *# | 41.90 ± 1.48 *# | 16.92± 0.81 *# | 31.85 ± 1.74 * |
| Binuclear hepatocytes per 100 liver cells | 6.65 ± 0.83 | 5.13 ± 0.46 | 3.13 ± 0.3 7 * | 3.75 ± 0.52 * | 5.00 ± 0.33 * | 4.05 ± 0.78 * |
| Kupffer cells per 100 liver cells | 14.28 ± 0.45 | 19.58 ± 0.60 * | 18.80 ± 0.72 * | 21.05 ± 0.53 * | 20.58 ± 0.48 * | 20.08 ± 0.75 * |
|
| ||||||
| Planimetric ratio of white to red pulp | 0.499 ± 0.034 | 0.624 ± 0.048 *#@ | 0.632 ± 0.040 *#@ | 0.753 ± 0.046 *#@ | 0.916 ± 0.057 | 0.950 ± 0.053 |
Notes: * statistically significant difference from the control value; # from the value of the group exposed to a full-dose ternary mixture and @ to a half dose ternary mixtures (p < 0.05 by the Student’s t-test).
Figure 6An example of Class A three-factor toxicity. Isobolograms of SiO2 + TiO2 combined subchronic liver toxicity assessed by the increase in the number of Kupffer cells as follows: (a) antagonism of unidirectional actions in the absence of a third agent and (b) additivity in the presence of Al2O3 NPs. MeO NP doses on the axes are plotted in mg per rat. Numbers on the isoboles show effect values.
Figure 7Isoboles for the combined subchronic toxicity of SiO2 + TiO2 for spleen assessed by the increase in the planimetric white to red pulp ratio as follows: (a) additivity of unidirectional actions in the absence of Al2O3 NP and (b) synergism in its presence (an example of Class A three-factor action). MeO NP doses on the axes are plotted in mg per rat; the numbers on the isoboles show ratio values.
An increase in the genomic DNA fragmentation factor of nucleated blood cells in rats following 18 intraperitoneal injections (during 6 weeks) of suspensions of various binary and ternary combinations of the MeO NPs as established AFLP assay ( ± Sx).
| Parameter | Control | Al2O3 + | Al2O3 + | TiO2 + | Al2O3 + | Al2O3 + |
|---|---|---|---|---|---|---|
| Fragmentation factor | 0.4023 + 0.0064 | 0.5416 + 0.0046 * | 0.4872 + 0.0041 * | 0.4391 + 0.0061 * | 0.4849 + 0.0068 * | 0.6430 + 0.0189 * |
Notes: * statistically significant difference from the control value; statistically significant differences between the groups administered the ternary mixture of MeO NPs in half and full doses (p < 0.05 by the Student’s t-test).
Figure 8Isobolograms for the binary combined genotoxicity of nanoparticles assessed by the increase in the fragmentation factor of nucleated blood cells as follows: (A) in the absence of a third agent under exposure to: (i) SiO2 + TiO2 (antagonism); (ii) SiO2 + Al2O3 (additivity); (iii) TiO2 + Al2O3 (synergism); (B) in the presence of a third agent: (iv) Al2O3 combined with SiO2 + TiO2 (additivity); (v) TiO2 combined with SiO2 + Al2O3 (a single-factor effect transforming into additivity); (vi) SiO2 combined with ТiO2 + Al2O3 (synergism). The axes plot the doses of relevant MeO NPs in mg per rat; the numbers on the isoboles denote the dimensionless value of the fragmentation factor.
The averaged elemental composition of the aerosol particles sampled in the workspace air of the aluminum titanium master alloy shop (in % to the sum of elements minus carbon and oxygen contained in the filter).
| Elements | Percent Content |
|---|---|
| Al | 14.8 |
| As | 0.1 |
| Ca | 8.2 |
| Cl | 5.6 |
| Cr | 2.5 |
| Cu | 0.1 |
| F | 1.1 |
| Fe | 2.9 |
| K | 3.8 |
| Mg | 11.4 |
| Na | 6.7 |
| Pb | 4.0 |
| S | 3.6 |
| Si | 12.0 |
| Sn | 0.5 |
| Ti | 17.5 |
| Zn | 5.2 |
| Total | 100 |
Figure 9A SEM image of Al2O3 particles at 50,000× magnification.
Figure 10Size distribution of the nanoparticles used in the experiment ((a)—Al2O3; (b)—TiO2; (c)—SiO2).